Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Inogen Inc.

Clinical trials sponsored by Inogen Inc., explained in plain language.

Inogen Inc. INGN NASDAQ

A medical technology company specializing in portable oxygen concentrators.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1

New breathing device aims to unclog lungs in bronchiectasis patients

Symptom relief Not yet recruiting

This pilot study will test the Simeox 200, a device designed to help clear mucus from the lungs, in 35 adults with bronchiectasis who produce a lot of phlegm. Participants will use the device twice daily for two weeks, and researchers will measure how much mucus is cleared, along…

Phase: NA • Sponsor: Inogen Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 09:09 UTC